Treatment of parvovirus infectious disease by a caninized neutralizing antibody to the virus

通过犬化病毒中和抗体治疗细小病毒感染性疾病

基本信息

  • 批准号:
    13660330
  • 负责人:
  • 金额:
    $ 2.11万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2002
  • 项目状态:
    已结题

项目摘要

(1) Monoclonal antibody (mAb) against a canine parvovirus (CPV) and its cDNA from the hybridoma cells.CPV was propagated in CRFK cells and purified through density gradient ultracentrifugations. Hybridomas were obtained by immunization of mice with the purified CPV and subsequent fusion of spleen cells with P3U1 myeloma cells. After screening by ELISA, IFA and virus neutralization, six clones (CP1a-6a) were established. RNA was isolated from CP3a, which produced immunoglobulin (Ig) of G1 subtype and showed the strongest binding activity, then the cDNA of Ig light (L) and heavy (H) chain were cloned by PCR, and their nucleotide sequences were determined.(2) Cloning of cDNA of canine IgSpleen cells were isolated a beagle dog, and RNA was extracted, cDNA of Ig was isolated using primer designed from the nucleotide sequences reported previously. Four clones of H chain were consisted of about 470 amino acid residues (aa) and the constant regions have a homology of 60-70% to human or mouse Ig gamma H chains. Two clones of L chain (one kappa (242 aa) and one lambda (231 aa)) were obtained, which have a homology of 58% and 85% in constant region with human Ig, respectively.(3) Construction of a caninized antibody by complementary determining region (CDR) grafting.CDR was determined in H and L chain of the CP3a mAb cDNA by the Contact definition. The CDR of canine H and L chains was assumed by the same definition. The caninized Ig gene was designed by replacing the canine CDR with CP3a's. The DNA fragments of H and L variable domains were synthesized by PCR, and conjugated to the DNA encoding corresponding constant region of Ig, respectively. Both DNA fragments were inserted into a transfer vector and the recombinant baculoviruses were obtained. The expression of caninized Ig was demonstrated by anti-canine Ig antisem in the culture supernatant of the Sf21 cells infected with the recombinant baculovirus.
(1)从杂交瘤细胞中获得犬细小病毒(CPV)单克隆抗体(mAb)及其cDNA。CPV在CRFK细胞中繁殖,并通过密度梯度超离心纯化。用纯化的CPV免疫小鼠,然后将脾细胞与P3U1骨髓瘤细胞融合,获得杂交瘤。经ELISA、IFA和病毒中和筛选,建立了6个克隆(CP1a-6a)。从CP3a中分离出结合活性最强的G1亚型免疫球蛋白(Ig)的RNA,用PCR方法克隆Ig轻(L)链和重(H)链cDNA,并测定其核苷酸序列。(2)犬igcdna的克隆从beagle犬中分离脾脏细胞,提取RNA,利用先前报道的核苷酸序列设计的引物分离igcdna。4个H链克隆包含约470个氨基酸残基(aa),恒定区与人或小鼠Ig γ H链同源性为60-70%。获得了2个L链克隆(1个kappa (242 aa)和1个lambda (231 aa)),在恒定区与人Ig的同源性分别为58%和85%。(3)互补决定区(CDR)接枝法构建犬化抗体。通过Contact definition测定CP3a mAb cDNA的H链和L链上的CDR。犬齿H链和L链的CDR采用相同的定义。用CP3a代替犬的CDR基因设计犬化Ig基因。用PCR方法合成H和L可变结构域的DNA片段,分别与编码Ig恒定区对应的DNA进行共轭。将这两个DNA片段插入转移载体中,获得重组杆状病毒。重组杆状病毒感染Sf21细胞的培养上清中,用抗犬Ig反sem证实了犬化Ig的表达。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

IWATA Akira其他文献

IWATA Akira的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('IWATA Akira', 18)}}的其他基金

Sound Recognition and Sound Localization for Hearing Impaired Person
听障人士的声音识别和声音定位
  • 批准号:
    22560417
  • 财政年份:
    2010
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The factor of muscle strain recurrence
肌肉拉伤复发的因素
  • 批准号:
    22700546
  • 财政年份:
    2010
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Improvement of neutralizing activity of anti-canine parvovirus antibodies through directed evolution.
通过定向进化提高抗犬细小病毒抗体的中和活性。
  • 批准号:
    15580281
  • 财政年份:
    2003
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Supervised Learning Rules of the Pulsed Neuron Model
脉冲神经元模型的监督学习规则
  • 批准号:
    11650422
  • 财政年份:
    1999
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A Neural Network Model with interaction between Extraneous Information and Internal Memory
外部信息与内部记忆相互作用的神经网络模型
  • 批准号:
    09650465
  • 财政年份:
    1997
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Elucidating the role of SERINC5 in SARS-CoV-2 infection
阐明 SERINC5 在 SARS-CoV-2 感染中的作用
  • 批准号:
    10624238
  • 财政年份:
    2022
  • 资助金额:
    $ 2.11万
  • 项目类别:
Elucidating the role of SERINC5 in SARS-CoV-2 infection
阐明 SERINC5 在 SARS-CoV-2 感染中的作用
  • 批准号:
    10372283
  • 财政年份:
    2022
  • 资助金额:
    $ 2.11万
  • 项目类别:
Regulation of cardiomyocyte inflammation during viral infection
病毒感染过程中心肌细胞炎症的调节
  • 批准号:
    10244888
  • 财政年份:
    2020
  • 资助金额:
    $ 2.11万
  • 项目类别:
Regulation of cardiomyocyte inflammation during viral infection
病毒感染过程中心肌细胞炎症的调节
  • 批准号:
    9894164
  • 财政年份:
    2020
  • 资助金额:
    $ 2.11万
  • 项目类别:
APOBEC3-mediated damage of host genomic DNA in vivo
APOBEC3 介导的体内宿主基因组 DNA 损伤
  • 批准号:
    8822043
  • 财政年份:
    2015
  • 资助金额:
    $ 2.11万
  • 项目类别:
Study of Human Bocavirus Gene Expression for Development of a Parvoviral Vector
人类博卡病毒基因表达的细小病毒载体开发研究
  • 批准号:
    8968485
  • 财政年份:
    2015
  • 资助金额:
    $ 2.11万
  • 项目类别:
Study of Human Bocavirus Gene Expression for Development of a Parvoviral Vector
人类博卡病毒基因表达的细小病毒载体开发研究
  • 批准号:
    9089981
  • 财政年份:
    2015
  • 资助金额:
    $ 2.11万
  • 项目类别:
Intranasal Stem-Cell Based Therapy for Glioblastoma
鼻内干细胞治疗胶质母细胞瘤
  • 批准号:
    9043959
  • 财政年份:
    2014
  • 资助金额:
    $ 2.11万
  • 项目类别:
Intranasal Stem-Cell Based Therapy for Glioblastoma
鼻内干细胞治疗胶质母细胞瘤
  • 批准号:
    8738225
  • 财政年份:
    2014
  • 资助金额:
    $ 2.11万
  • 项目类别:
Intranasal Stem-Cell Based Therapy for Glioblastoma
鼻内干细胞治疗胶质母细胞瘤
  • 批准号:
    9203217
  • 财政年份:
    2014
  • 资助金额:
    $ 2.11万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了